Table 1.
Self-injectable and oral DMDs
| Type | Generic name | Brand namea |
|---|---|---|
| Self-injectable DMD | Interferon beta-1a | Avonex® |
| Interferon beta-1b | Betaseron® | |
| Glatiramer acetate | Copaxone® | |
| Interferon beta-1b | Extavia® | |
| Interferon beta-1a | Rebif ® | |
| Oral DMD | Teriflunomide | Aubagio® |
| Fingolimod | Gilenya® | |
| Dimethyl fumarate | Tecfidera® |
Notes:
Aubagio® (teriflunomide) is a registered trademark of Genzyme Corporation (Cambridge, MA, USA); Avonex® (interferon beta-1a) is a registered trademark of Biogen (Cambridge, MA, USA); Betaseron® (interferon beta-1b) is a registered trademark of Bayer (Whippany, NJ, USA); Copaxone® (glatiramer acetate injection) is a registered trademark of Teva Pharmaceutical Industries Ltd. (Overland Park, KS, USA); Extavia® (interferon beta-1b) is a registered trademark of Novartis AG (East Hanover, NJ, USA); Gilenya® (fingolimod) is a registered trademark of Novartis AG (Stein, Switzerland); Rebif ® (interferon beta-1a) is a registered trademark of EMD Serono, Inc. (Rockland, MA, USA; a business of Merck KGaA, Darmstadt, Germany); Tecfidera® (dimethyl fumarate) is a registered trademark of Biogen.
Abbreviation: DMD, disease-modifying drug.